Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients 24-week, crossover, treat to target trial in a single center.pdf.pdf
Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients 24-week, crossover, treat to target trial in a single center.pdf.pdf
Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients 24-week, crossover, treat to target trial in a single center.pdf 来自淘豆网www.taodocs.com转载请标明出处.